CLDX position history
The shares of Celldex Therapeutics (CLDX) that Palo Alto Investors LP reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2026 Q1: 296,408 shares, $9.4M, 1.4% of portfolio, New
- 2026 Q2: 399,856 shares, $15M, 2.1% of portfolio, Add +34.9%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|